The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
Massimo Filippi(Vita-Salute San Raffaele University), Roberto Vuotto(Vita-Salute San Raffaele University), Roberta Messina(Vita-Salute San Raffaele University), Debora Raimondi(Novartis (Italy)), Alessandra Splendiani(University of L'Aquila), Paola Valsasina(Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele), Ilaria Cetta(Vita-Salute San Raffaele University), Licia Grazzi(Fondazione IRCCS Istituto Neurologico Carlo Besta), Simona Sacco(University of L'Aquila), Cristina Tassorelli(University of Pavia), Valeria Caponnetto(University of L'Aquila), Daniele Martinelli(University of Pavia), Luca Dall’Occhio(University of Basel), Raffaele Ornello(University of L'Aquila), Maria A. Rocca(Vita-Salute San Raffaele University), Federico Bruno(University of L'Aquila), Angela Campanella, Antonio Russo(University of Campania "Luigi Vanvitelli"), Bruno Colombo(Vita-Salute San Raffaele University), Renato Turrini(Novartis (Italy)), Anna Pichiecchio(University of Pavia), Marcello Silvestro(University of Naples Federico II), Marta Bartezaghi(Novartis (Italy))
Cited by 12
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k